Enterome to Feature Promising Phase 1 Clinical Data With its Lead Candidate EB8018 for Crohn's Disease at the Digestive Disease Week 2018

PARIS and CAMBRIDGE, Massachusetts, June 1, 2018 /PRNewswire/ -- Enterome SA, a clinical-stage biotech company pioneering innovative therapies to treat microbiome-associated diseases with a focus on inflammatory bowel diseases (IBD) and immuno-oncology (IO) indications, announces it...

from PR Newswire: //https://ift.tt/2kDosIb